TABLE 2.
Comparison of GLP‐1 analogue interventions and control conditions across studies.
| Study ID | Intervention group | Control group |
|---|---|---|
| Ferdinando Carlo Sasso (2012) | DPP‐4 inhibitor | Placebo |
| Lu Lin (2020) | Liraglutide | NA |
| Xiangjin Xu (2019) | Liraglutide | NA |
| Emilie H. Zobel (2021) | Liraglutide | Placebo |
| Juan Pablo Frias (2018) | LY3298176 | Placebo |
| Eraydin (2018) | Liraglutide | Placebo |
| Liselotte van Bloemendaal (2014) | Exenatide | Placebo |
| Nauck (2003) | GLP‐1 analogues | Healthy patients |
| M. A. Nauck (2006) | Liraglutide | Metformin |